×
About 1,141 results

ALLMedicine™ Lipid Disorders Center

Research & Reviews  521 results

Impact of fenofibrate therapy on serum uric acid concentrations: a review and meta-anal...
https://doi.org/10.1507/endocrj.EJ20-0808
Endocrine Journal; Zhang J, Ji X et. al.

Mar 18th, 2021 - Fenofibrate is a marketed fibric acid derivative for lipid-lowering in patients with lipid disorders. Numerous studies have proven fenofibrate had a certain effect on serum uric acid, here we conducted this study to quantitatively assess the effec...

Impact of Lifestyle Intervention Programs for Children and Adolescents with Overweight ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923753
International Journal of Environmental Research and Publi... Bondyra-Wiśniewska B, Myszkowska-Ryciak J et. al.

Mar 6th, 2021 - Excessive body mass is a health problem among children and adolescents that contributes to the occurrence of lipid disorders and abnormal blood pressure. Effective treatment of excessive body mass in children is essential for the health of populat...

Consensus Statement by the American Association of Clinical Endocrinologists and Americ...
https://doi.org/10.4158/CS-2020-0490
Endocrine Practice : Official Journal of the American Col... Handelsman Y, Jellinger PS et. al.

Jan 20th, 2021 - The treatment of lipid disorders begins with lifestyle therapy to improve nutrition, physical activity, weight, and other factors that affect lipids. Secondary causes of lipid disorders should be addressed, and pharmacologic therapy initiated base...

Elevated atherogenic index and higher triglyceride increase risk of kidney function dec...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745844
Renal Failure; Huang F, Wang L et. al.

Dec 14th, 2020 - This study explored whether lipid disorders or an elevated atherogenic index of plasma (AIP, a risk factor for cardiovascular diseases) could predict major kidney function decline. We conducted a retrospective 7-year cohort study of 3712 Chinese a...

see more →

Guidelines  11 results

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of ...
http://www.onlinejacc.org/content/early/2018/11/02/j.jacc.2018.11.003
Grundy, S.,et al

Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLIN.

Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.
https://www.ncbi.nlm.nih.gov/pubmed/28075093
American Family Physician;

Jan 11th, 2017 - Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.|2017||therapeutic use,diagnosis,therapy,diagnosis,drug therapy,

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventiv...
https://doi.org/10.1001/jama.2016.15450
JAMA , Bibbins-Domingo K et. al.

Nov 13th, 2016 - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid...

Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task ...
https://doi.org/10.1001/jama.2016.9852
JAMA , Bibbins-Domingo K et. al.

Aug 17th, 2016 - Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovas...

Screening for Lipid Disorders in Children and Adolescents: Clinical Summary
https://allmedx.com/USPSTFPDF/lipidscreening_ch-summary.pdf

Aug 2nd, 2016 - Figure. Screening for Lipid Disorders in Children and Adolescents: Clinical Summary Population Asymptomatic children and adolescents 20 years or younger Recommendation No recommendation. Grade: I (insufficient evidence) Ri...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  565 results

Impact of fenofibrate therapy on serum uric acid concentrations: a review and meta-anal...
https://doi.org/10.1507/endocrj.EJ20-0808
Endocrine Journal; Zhang J, Ji X et. al.

Mar 18th, 2021 - Fenofibrate is a marketed fibric acid derivative for lipid-lowering in patients with lipid disorders. Numerous studies have proven fenofibrate had a certain effect on serum uric acid, here we conducted this study to quantitatively assess the effec...

Impact of Lifestyle Intervention Programs for Children and Adolescents with Overweight ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923753
International Journal of Environmental Research and Publi... Bondyra-Wiśniewska B, Myszkowska-Ryciak J et. al.

Mar 6th, 2021 - Excessive body mass is a health problem among children and adolescents that contributes to the occurrence of lipid disorders and abnormal blood pressure. Effective treatment of excessive body mass in children is essential for the health of populat...

Consensus Statement by the American Association of Clinical Endocrinologists and Americ...
https://doi.org/10.4158/CS-2020-0490
Endocrine Practice : Official Journal of the American Col... Handelsman Y, Jellinger PS et. al.

Jan 20th, 2021 - The treatment of lipid disorders begins with lifestyle therapy to improve nutrition, physical activity, weight, and other factors that affect lipids. Secondary causes of lipid disorders should be addressed, and pharmacologic therapy initiated base...

Elevated atherogenic index and higher triglyceride increase risk of kidney function dec...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745844
Renal Failure; Huang F, Wang L et. al.

Dec 14th, 2020 - This study explored whether lipid disorders or an elevated atherogenic index of plasma (AIP, a risk factor for cardiovascular diseases) could predict major kidney function decline. We conducted a retrospective 7-year cohort study of 3712 Chinese a...

see more →

News  43 results

'Biosimilar' Insulin Glargine, Semglee, Approved for Diabetes in US
https://www.medscape.com/viewarticle/932275

Jun 12th, 2020 - Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the Food and Drug Administration announced June 11. "Long-acting insulin products li...

200 cardiovascular drugs now in development
https://www.mdedge.com/chestphysician/article/159901/acute-coronary-syndromes/200-cardiovascular-drugs-now-development
Richard Franki, MDedge News

Mar 2nd, 2018 - Heart failure, with 42 medicines currently in development, is the leading area for new treatments of cardiovascular disease, according to Pharmaceutical Research and Manufacturers of America. One of those 42 treatments is “a nonviral gene therapy.

Is it time to abandon fasting for routine lipid testing?
https://www.mdedge.com/ccjm/article/152901/cardiology/it-time-abandon-fasting-routine-lipid-testing?channel=35
Zareen Farukhi, MD, Samia Mora, MD, MHS

Dec 1st, 2017 - Yes. The time has come to change the way we think about fasting before routine lipid testing.

Supplements Affect NT-ProBNP; Cord Stem Cells; ED Exit Sans Stress Test
https://www.medpagetoday.com/cardiology/prevention/68214

Sep 28th, 2017 - Common over-the-counter doses of biotin supplements -- popular for hair growth, lipid disorders, and other presumptive benefits -- interfere with assays for N-terminal pro-brain natriuretic peptide (NT-proBNP) and other common analytes in blood, r...

USPSTF on Kids' Lipids; ICU Overuse; BP Variability
https://www.medpagetoday.com/cardiology/prevention/59656

Aug 11th, 2016 - The U.S. Preventive Services Task Force concluded that there was too little evidence to make any recommendations on universally screening children and adolescents for lipid disorders. But the panel's conclusion drew both praise and censure. "We di...

see more →